DNA vaccines - A modern gimmick or a boon to vaccinology?

Critical Reviews in Immunology

Volumn 17, Issue 2, 1997, Pages 139-154

  Manickan, Elanchezhiyan ^a   Karem, Kevin L ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

CTLs and CD4+ T cells; cytokines; gene therapy; infectious disease; mucosal delivery; plasmids; virus

Indexed keywords

ANTIGEN; BUPIVACAINE; CHOLERA TOXIN; COLECALCIFEROL; DNA VACCINE; PLASMID DNA;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; CONTROLLED STUDY; DNA DETERMINATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; GENE THERAPY; GENETIC MANIPULATION; HERPES VIRUS; IMMUNOPROPHYLAXIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION;

EID: 0030977720     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v17.i2.20     Document Type: Review

References (70)

1. Atanasiu, P., Production de tumeurs chez le hamster par inoculation d'acide de-oxynucleique extrait de cultures de tissues infectees parc le virus de polyome, Acad. Sci., 254, 4228, 1962.
2. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., and Feigner, P. L., Direct gene transfer into mouse muscle in vivo, Science, 247, 1465, 1990.
3. Robinson, H. L., Hunt, L. A., and Webster, R. G., Protection against a lethal influenza virus challenge by immunization with haemagglutinin-expressing plasmid DNA, Vaccine, 11, 975, 1993.
4. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Feigner, P. L., Dwarki, J. J., Gromkowski, S. H., Deck, R., DeWitt, C. M., Friedman, A., Hawe, L. A., Laender, K. R., Martinez, D., Perry, H. C., Shiver, J., Montgomery, D. L., and Liu, M. A., Heterologous protection against influenza by injection of DNA encoding a viral protein, Science, 254, 1745, 1993.
5. Rouse, R. J. D., Nair, S. K., Lydy, S. L., Bowen, J. C., and Rouse B. T., Induction of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins, J. Virol., 68, 5685, 19??.
6. Yankauckas, M. A., Morrow, J. E., Parker, S. E., Abai, A., Rhodes, G. H., Dwarki, V. J., and Gromkosvsky, S. H., Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP-gene, DNA Cell Biol., 12, 771, 1993.
7. Scherie, P. A. and Gerhard, W., Functional analysis of influenza specific helper T-cell clones in vivo. T-cells specific for internal viral proteins provide cognate help for B-cell responses to hemagglutinin, J. Exp. Med., 164, 1114, 1986.
8. Palladino, G., Mozkzanowska, K., Washko, G., and Gerhard, W., Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotype can cure influenza virus pneumonia in SCID mice, J. Virol., 69, 2075, 1995.
9. Johansson, B. E., Bucher, D. J., and Kilborne, E. D., Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but inducing contrast types of immunity to infection, J. Virol., 63, 5721, 1989.
10. Donnelly, J. J., Friedman, A., Martinez, D., Montgomery, D. L., Shiver, J. W., Motzel, S. L., Ulmer, J. B., and Liu, M. A., Preclinical efficacy of prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus, Nature Med., 1, 583, 1995.
11. Smith, W., Andrews, C. H., and Laidlaw, P. P., A virus obtained from influenza patients, Lancet, 2, 66, 1983.
12. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L., DNA vaccines: protective immunization by parenteral, mucosal, and gene gun inoculations, Proc. Natl. Acad. Sci. U.S.A., 90, 11478, 1993.
13. Jutewicz, D. M., Morin, M. J., Robinson, H. L., and Webster, R. G., Antibody forming cell response to viral challenge in mice immunized with DNA encoding the influenza virus hemagglutinin, J. Virol., 69, 7712, 1995.
14. Kutinova, L., Benda, R., and Kalos, Z., Placebo controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences, Vaccine, 6, 223, 1988.
15. Cox, G. J. M., Zamb, T. J., and Babiuk, L. A., Bovine herpes virus. I. Immuneresponses in mice and cattle injected with plasmid DNA, J. Virol., 61, 5664, 1993.
16. + T lymphocytes, J. Immunol., 155, 259, 1995.
17. Donnelly, J. J., Ulmer, J. B., and Liu, M. A., Immunization with polynucleotides: a novel approach to vaccination, Immunologist, 2/1, 20, 1994.
18. Kriesel, J. D., Spruance, S. L., Daynes, R. A., and Araneo, B. A., Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease, J. Infect. Dis., 173, 536, 1996.
19. Bourne, N., Stanberry, L. R., Bernstein, D. I., and Lew, D., DNA immunization against experimental genital herpes simplex virus infection, J. Infect. Dis., 173, 800, 1996.
20. Manickan, E., Yu, Z., Rouse, R. J. D., Wire, W. S., and Rouse, B. T., Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein, ICP-27, Viral Immunol., 8, 53, 1995.
21. Simmons, A. and Nash, A. A., Zosteriform spread of HSV as a novel of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease, J. Virol., 52, 816, 1984.
22. + T cells, J. Virol., 69, 4711, 1995.
23. Stanberry, L., R., Herpes immunization - on the threshold, J. Infect. Dis., 1996, in press.
24. Hoffmann, S. L., Sedegah, M., and Hedstrom, R. C., Protection against malaria by immunization with Plasmodium yoedii circumsporozoite protein nucleic acid vaccine, Vaccine, 12, 1529, 1994.
25. Nardin, E. H. and Nussenzweig, R. S., T-cell responses to preerythrocytic stages of malaria: role in protection and vaccine development against preerythrocytic stages, Annu. Rev. Immunol., 11, 687, 1993.
26. Tascon, R. E., Colston, J. J., Rango, S., Starropoulos, E., Gregory, D., and Lowrie, D. B., Vaccination against tuberculosis, Nature Med., 1996, in press.
27. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B., and Bloom, B. R., Major histocompatibility complex class I-restricted T-cells are required for resistance to mycobacterium tuberculosis infection, Proc. Natl. Acad. Sci. U.S.A., 89, 12013, 1992.
28. Lowrie, D. B., Tascon, R. E., Colston, M. J., and Silva, C. L., Toward a DNA vaccine against tuberculosis, Vaccine, 12, 1537, 1995.
29. Whalen, R. G. and Davis, H. L., DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen, Clin. Immunol. Immunopathol., 75, 1, 1995.
30. Shirmbeck, R., Bohm, W., Ando, K., Chisari, F. V., and Reimann, J., Nucleic acid vaccination primes hepatitis B virus surface antigen specific cytotoxic T lymphocytes in nonresponder mice, J. Virol., 69, 5929, 1995.
31. Barry, M. A., Lai, W. C., and Johnston, S. A., Protection against mycoplasma infection using expression library immunization, Nature, 377, 632, 1995.
32. Lagging, L. M., Mayer, K., Hoft, D., Houghton, M., Belshe, R. B., and Ray, R., Immune response to plasmid DNA encoding the hepatitis C virus core protein, J. Virol., 69, 5859, 1995.
33. Xiang, Z. Q., Spitalnik, S., Tran, M., Wunner, W. H., Cheng, J., and Ertl, H. C. J., Vaccination with plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus, Virology, 199, 132, 1994.
34. Wang, B., Ugen, K. E., Srikantan, V., Agadjanyan, M. G., Dang, K., Refaeli, Y., Sato, A. I., Boyer, J., Williams, W. V., and Weiner, D. B., Gene inoculation generates immune responses against human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. U.S.A., 90, 4156, 1993.
35. Wang, B., Boyer, J., Srikantan, V., Coney, L., Carrano, R., Phan, C., Merka, M., Dang, K., Agadjanan, M., Gilbert, L., Ugen, K. E., Williams, W. V., and Weiner, D. B., DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and non-human primates, DNA Cell Biol., 12, 799, 1993.
36. Caese, K. B. and Berzofsky, J. A., Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development, Annu. Rev. Immunol., 12, 932, 1994.
37. h2 switch is a critical step in the etiology of HIV infection, Immunol. Today, 14, 107, 1993.
38. Wang, B., Merva, M., Dang, K., Ugen, K. E., Williams, W. V., and Weiner, D. B., Immunization by direct DNA inoculation induces rejection of tumor cell challenge, Human Gene Therapy, 6, 407, 1995.
39. Pardoll, D. M. and Beckerleg, A. M., Exposing the immunology of naked DNA vaccines, Immunity, 3, 165, 1995.
40. Matzinger, P., Tolerance, danger, and the extended family, Annu. Rev. Immunol., 12, 991, 1994.
41. Xiang, Z. and Ertl, H. C., Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines, Immunity, 2, 129, 1995.
42. Germain, R. N., The biochemistry and cell biology of antigen processing and presentation, Annu. Rev. Immunol., 11, 403, 1993.
43. Bevan, M. J., Antigen presentation to cytotoxic T-lymphocytes in vivo, J. Exp. Med., 182, 639, 1995.
44. Kovacsvics-Bankowsky, M. and Rock, K. L., A phagosome-to-cytosol pathway for exogenous antigen presented on MHC-class I molecules, Science, (Wash. D.C.), 267, 243, 1995.
45. Nair, S., Buiting, A. M., Rouse, R. J. D., Rooigen, N. V., Haung, L., and Rouse, B. T., Role of macrophages and dendritic cells in primary cytotoxic T-lymphocyte responses, Int. Immunol., 7, 679, 1995.
46. Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findley, K., Normack, S. J., and Harding, C. V., Phagocytic processing of bacterial antigens for class I MHC presentation to T cells, Nature, 361, 153, 1993.
47. Arnold, D., Faath, S., Rammensee, H. G., and Schild, H., Cross priming of minor histocompatibility antigen specific cytotoxic T cells upon immunization with the heat shock protein gp 96, J. Exp. Med., 182, 885, 1995.
48. Suto, R. and Srivastava, P. K., A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides, Science, 269, 1585, 1995.
49. Staats, H. F., Jackson, R. J., Marinano, M., Takahoshi, I., Kiyono, H., and McGee, J. R., Mucosal immunity to infection with implications for vaccinedevelopment, Curr. Opin. Immunol., 6, 572, 1994.
50. Jackson, R. J., Fugihashi, K., Xu-Amano, J., Kiyono, H., Elson, C. O., and McGee, J. R., Optimizing oral vaccines and induction of systemic and mucosal B-cell and antibody responses to tetanus toxpid by use of cholera toxin as an adjuvant, Infect. Immun., 61, 4272, 1993.
51. Sizemore, D. R., Branstrom, A. A., and Sadoff, J. C., Attenuated Shigella as a DNA vechicle for DNA-mediated immunization, Science, 270, 299, 1995.
52. Gould-Folgerite, S., Mucosal and systemic immunization using cochleate and liposome vaccine, J. Liposome Res., 1996, in press.
53. Linsley, P. S. and Ledbetter, J. A., The role of the CD28 receptor during T-cell responses to antigen, Annu. Rev. Immunol., 11, 191, 1993.
54. Trinchieri, G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adoptive immunity, Annu. Rev. Immunol., 13, 251, 1995.
55. Bluestone, J. A., New perspectives of CD28-B7-mediated T-cell costimulation, Immunity, 2, 555, 1995.
56. h2 effector cells in the experimental Leishmaniasis, J. Immunol., 153, 4142, 1994.
57. Chisari, F. V. and Ferrari, C., Hepatitis B virus immunopathogenesis, Annu. Rev. Immunol., 13, 29, 1995.
58. Openshaw, P. J. M., Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin. Immunopathol., 17, 187, 1995.
59. Kurane, I. and Ennis, F. A., Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever, Semin. Virol., 5, 443, 1994.
60. Pantaleo, G. and Fauci, A. S., New concepts in the immunopathogenesis of HIV infection, Annu. Rev. Immunol., 13, 487, 1995.
61. Buchmeier, M. J., Welsh, R. M., Dutko, F. J., and Oldstone, M. B. A., The virology and immunology of lymphocytic choriomeningitis virus, Adv. Immunol., 36, 275, 1980.
62. Yokoyamo, M., Zhang, J., and Whitton, J. L., DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection, J. Virol., 69, 2684, 1995.
63. Zarozinski, C. C., Finan, E. F., Selin, L. K., Robinson, H. L., and Welsh, R. M., Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein, J. Immunol., 154, 4010, 1995.
64. Rogy, M. A., Auffenberg, T., Espat, J. N., Philip, R., Remick, D., Wollenberg, G. K., Copeland, E. M., III, and Moldawer, L. L., Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses, J. Exp. Med., 181, 2289, 1995.
65. Yasutomi, U., Robinson, H. L., Lu, S., Mustata, F., Lekutis, C., Arthos, J., Mullins, J. I., Voss, G., Manson, K., Wyand, M., and Letvin, N., Simian immunodeficiency virus specific cytotoxic T-lymphocyte induction through DNA vaccination of Rhesus monkeys, J. Virol., 70, 678, 1996.
66. Xu, D. and Liew, F. Y., Protection against Leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology, 84, 173, 1995.
67. Ciernik, I. F., Bezzofsky, J. A., and Carbone, D. P., Induction of cytotoxic lymphocytes and antitumor immunity with DNA vaccines expressing single T-cell epitopes, J. Immunol., 156, 2369, 1996.
68. Bright, R. K., Beames, B., Shearer, M. H., and Kennedy, R. C., Protection against lethal tumor challenge with SV-40-transformed cells by the direct injection of DNA encoding SV-40 large tumor antigen, Cancer Res., 56, 1126, 1996.
69. b mice, J. Immunol., 156, 3687, 1996.
70. + T cell-, interferon of-, and nitric oxide-dependent immunity, J. Exp. Med., 183, 1739, 1996.